Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

ARS Pharmaceuticals, Inc. SPRY

Set alert

Price alert · SPRY

All alert types
3.05 USD -0.33 -9.76%

At close · Nov 2

2.99 -0.06 -1.92%

After hours · Nov 2, 4:00 PM ET

Bid
3.04 × 2
Ask
3.05 × 2
2.91 Day range 3.48
2.91 52-week range 13.15
YTD
-73.82%
1 year
-65.96%
Open
3.40
Prev close
3.38
Mkt cap
303.31M
Vol
2.13M
Avg vol
1.65M
EPS
-1.96
P/E
0.00
Div yield
0.00%
More statistics
Low
2.91
High
3.48
Forward P/E
-11.01
Beta
0.83
Short ratio
13.70
Inst. own
95.47%
Dividend
0.00
Ex-div date
Earnings
Aug 13, 2026
50-d avg
8.64
200-d avg
9.38
1y target
28.80

5D chart

Chart tools
Interval
1m5m15m30m

Signals (83)
NameTimeAgo
MACD: Sell SignalNov 2, 2:40 PM13 hours ago
RSI: OversoldNov 2, 2:35 PM13 hours ago
SMA: BullishNov 2, 2:10 PM14 hours ago
MACD: Buy SignalNov 2, 2:05 PM14 hours ago
MACD: Sell SignalNov 2, 1:35 PM14 hours ago
RSI: OversoldNov 2, 1:05 PM15 hours ago
RSI: OversoldNov 2, 12:45 PM15 hours ago
RSI: OversoldNov 2, 12:20 PM15 hours ago
MACD: Buy SignalNov 2, 11:55 AM16 hours ago
MACD: Sell SignalNov 2, 11:50 AM16 hours ago
SMA: BearishNov 2, 11:40 AM16 hours ago
MACD: Buy SignalNov 2, 11:40 AM16 hours ago
RSI: OversoldNov 2, 11:40 AM16 hours ago
SMA: BullishNov 2, 11:30 AM16 hours ago
RSI: OversoldNov 2, 10:30 AM17 hours ago
MACD: Sell SignalNov 2, 10:05 AM18 hours ago
SMA: BearishNov 2, 9:55 AM18 hours ago
SMA: BullishNov 2, 9:30 AM18 hours ago
SMA: BullishNov 2, 9:30 AM18 hours ago
SMA: BearishOct 30, 3:15 PM3 days ago

Newest 20 of 83.

Financial health

Altman Z-Score

-3.17 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -6.7×
FY 2018: -47.2×FY 2019: -34.7×FY 2020: -1509×FY 2021: -9.5×FY 2022: -9.8×FY 2023: -9.6×FY 2024: 128×FY 2025: -6.7×
FY 2018 5y median -9.5× FY 2025
P/S 13.6×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 90.2×FY 2021: 34.9×FY 2022: 259×FY 2023: 17393×FY 2024: 11.5×FY 2025: 13.6×
FY 2018 5y median 34.9× FY 2025
P/B 10.1×
FY 2018: 45.4×FY 2019: -148×FY 2020: -114×FY 2021: -6.1×FY 2022: 1.2×FY 2023: 2.3×FY 2024: 4.0×FY 2025: 10.1×
FY 2018 5y median 2.3× FY 2025
P/FCF -6.7×
FY 2018: -47.7×FY 2019: -43.5×FY 2020: 197×FY 2021: -10.9×FY 2022: -8.5×FY 2023: -8.8×FY 2024: 78.8×FY 2025: -6.7×
FY 2018 5y median -8.5× FY 2025
EV/EBITDA -7.2×
FY 2018: -48.2×FY 2019: -37.0×FY 2020: -3442×FY 2021: -7.1×FY 2022: -3.8×FY 2023: -8.3×FY 2024: 116×FY 2025: -7.2×
FY 2018 5y median -7.1× FY 2025
EV/Sales 14.3×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 89.3×FY 2021: 25.7×FY 2022: 99.4×FY 2023: 15036×FY 2024: 10.9×FY 2025: 14.3×
FY 2018 5y median 25.7× FY 2025
FCF Yield -14.9%
FY 2018: -2.1%FY 2019: -2.3%FY 2020: 0.5%FY 2021: -9.2%FY 2022: -11.8%FY 2023: -11.4%FY 2024: 1.3%FY 2025: -14.9%
FY 2018 5y median -11.4% FY 2025

Profitability

Gross Margin 75.8%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 21.1%FY 2021: 96.1%FY 2022: -1200.9%FY 2023: 100.0%FY 2024: 76.9%FY 2025: 75.8%
FY 2018 5y median 76.9% FY 2025
Operating Margin -212.9%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: -2.6%FY 2021: -353.3%FY 2022: -2698.8%FY 2023: -225066.7%FY 2024: -3.5%FY 2025: -212.9%
FY 2018 5y median -353.3% FY 2025
Net Margin -203.3%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: -6.0%FY 2021: -367.7%FY 2022: -2635.4%FY 2023: -181216.7%FY 2024: 9.0%FY 2025: -203.3%
FY 2018 5y median -367.7% FY 2025
ROE -149.9%
FY 2018: -96.6%FY 2019: 427.8%FY 2020: 7.6%FY 2021: 64.7%FY 2022: -12.7%FY 2023: -23.6%FY 2024: 3.1%FY 2025: -149.9%
FY 2018 5y median -12.7% FY 2025
ROIC -62.2%
FY 2018: -70.6%FY 2019: -240.3%FY 2020: -2.3%FY 2021: -34.2%FY 2022: -12.9%FY 2023: -29.2%FY 2024: -0.9%FY 2025: -62.2%
FY 2018 5y median -29.2% FY 2025
ROA -52.3%
FY 2018: -63.8%FY 2019: -153.2%FY 2020: -4.0%FY 2021: -32.9%FY 2022: -12.3%FY 2023: -23.3%FY 2024: 2.3%FY 2025: -52.3%
FY 2018 5y median -23.3% FY 2025

Growth (YoY)

Revenue -5.5%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: -69.1%FY 2022: -76.1%FY 2023: -97.7%FY 2024: 297063.3%FY 2025: -5.5%
FY 2018 FY 2025
Operating Income -5720.6%
FY 2018: 0.0%FY 2019: -31.4%FY 2020: 98.1%FY 2021: -4048.0%FY 2022: -82.6%FY 2023: -90.1%FY 2024: 95.4%FY 2025: -5720.6%
FY 2018 FY 2025
EPS (diluted) -2327.9%
FY 2018: 0.0%FY 2019: -35.8%FY 2020: 95.7%FY 2021: -2180.1%FY 2022: -24.3%FY 2023: 34.5%FY 2024: 113.7%FY 2025: -2327.9%
FY 2018 FY 2025
Free Cash Flow -1418.5%
FY 2018: 0.0%FY 2019: -9.6%FY 2020: 142.9%FY 2021: -316.0%FY 2022: -128.6%FY 2023: -47.6%FY 2024: 121.8%FY 2025: -1418.5%
FY 2018 FY 2025

Financial Health

Current Ratio 7.3×
FY 2018: 4.0×FY 2019: 0.6×FY 2020: 3.2×FY 2021: 7.4×FY 2022: 51.0×FY 2023: 96.8×FY 2024: 14.3×FY 2025: 7.3×
FY 2018 5y median 14.3× FY 2025
Quick Ratio 7.1×
FY 2018: 4.0×FY 2019: 0.6×FY 2020: 3.2×FY 2021: 7.4×FY 2022: 51.0×FY 2023: 96.8×FY 2024: 14.0×FY 2025: 7.1×
FY 2018 5y median 14.0× FY 2025
Debt / Equity 0.8×
FY 2018: 0.4×FY 2019: -2.8×FY 2020: -0.7×FY 2021: -0.3×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.8×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA -0.3×
FY 2018: 0.7×FY 2019: -0.3×FY 2020: 31.3×FY 2021: 2.6×FY 2022: 6.1×FY 2023: 1.3×FY 2024: -6.1×FY 2025: -0.3×
FY 2018 5y median 1.3× FY 2025
Interest Coverage -69.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: -16.2×FY 2021: -184×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -69.0×
FY 2018 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31